RxDoctor Payments DataLook up a doctor →

Cristine Radojicic, MD

Allergy & Immunology · Durham, NCNPI 1245294206

Payments from drug & device makers

$557,555in general payments, 2019–2025

Across 531 payments — averaging $1050.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$477K
  • Ionis Pharmaceuticals, Inc.$22K
  • Biocryst Pharmaceuticals, Inc.$21K
  • Genentech USA, Inc.$17K
  • Pharming Healthcare, Inc.$13K
  • Optinose US, Inc.$3K
  • plus $4K from 7 others
$4,052in research payments, 2019–2025

Across 4 payments — averaging $1012.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$557,555 in reported general payments places this provider in the 90th percentile of 140 allergy & immunology providers in North Carolina.

See all allergy & immunology providers in North Carolina

Medicare billing

Part B allowed, 2024
$44,685
Medicare patients
174
Services billed
2,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →